sparsentan will minimize the level or outcome of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Warning/Check. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and reduces efficacy connected to these substrates. Keep away from or Use Alternate Drug. Stay away from coadministration of sensitive CYP3A4 substrates with https://modafinil76542.targetblogs.com/26608961/helping-the-others-realize-the-advantages-of-modafinil